rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Andrew J. D'Silva

Chief Business Officer

Company insider

Files Form 4 as: Chief Business Officer, OptimizeRx.

In numbers

Trades disclosed
13
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
21 Aug 2025
Last trade
1 Oct 2026
Last filed
2 Oct 2026

Companies traded

Where they are an officer
OPRX OptimizeRxOfficer · Business Services · last 1 Oct 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
1 Oct 2026filed 2 Oct 2026OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code F$3,473414 at $8.39filing
1 Sep 2026filed 2 Sep 2026OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code F$11K1,432 at $7.86filing
1 Sep 2026filed 2 Sep 2026OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code F$11K1,432 at $7.86filing
21 Aug 2026filed 24 Aug 2026OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code F$9,5841,243 at $7.71filing
21 Aug 2026filed 24 Aug 2026OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code F$9,5841,243 at $7.71filing
20 Aug 2026filed 24 Aug 2026OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code A—57,600 at $0.00filing
20 Aug 2026filed 24 Aug 2026OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code A—57,600 at $0.00filing
19 Dec 2025filed 22 Dec 2025OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code F$9,498703 at $13.51filing
11 Dec 2025filed 15 Dec 2025OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code F$12K868 at $14.03filing
3 Oct 2025filed 7 Nov 2025OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code F$15K794 at $18.75filing
1 Oct 2025filed 7 Nov 2025OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code F$7,858414 at $18.98filing
21 Aug 2025filed 7 Oct 2025OPRX OptimizeRxoption or derivative · Business ServicesSEC FORM 4 Code A—23,437 at $0.00filing
21 Aug 2025filed 7 Oct 2025OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code A—10,417 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Stephen L. SilvestroChief Executive Officer · Chief Executive Officer at OptimizeRx, filing Form 4 there in the last year
Marion Odence-FordChief Legal & Admin Officer · Chief Legal & Admin Officer at OptimizeRx, filing Form 4 there in the last year
Edward StelmakhChief Finance & Strat Officer · Chief Finance & Strat Officer at OptimizeRx, filing Form 4 there in the last year
Brendan W. MerrellChief Operating Officer · Chief Operating Officer at OptimizeRx, filing Form 4 there in the last year
James Paul LangDirector · Director at OptimizeRx, filing Form 4 there in the last year